AAAAAA
Results:
1-18
|
Results: 18
Authors:
Bargman, JM
Thorpe, KE
Churchill, DN
Citation: Jm. Bargman et al., Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study, J AM S NEPH, 12(10), 2001, pp. 2158-2162
Authors:
Oliver, MJ
Edwards, LJ
Churchill, DN
Citation: Mj. Oliver et al., Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms, J AM S NEPH, 12(1), 2001, pp. 151-156
Authors:
Clase, CM
St Pierre, MW
Churchill, DN
Citation: Cm. Clase et al., Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease, NEPH DIAL T, 16(9), 2001, pp. 1925-1929
Authors:
Margetts, PJ
Churchill, DN
Alexopoulou, I
Citation: Pj. Margetts et al., Interstitial nephritis in patients with inflammatory bowel disease treatedwith mesalamine, J CLIN GAST, 32(2), 2001, pp. 176-178
Authors:
Rabbat, CG
Thorpe, KE
Russell, JD
Churchill, DN
Citation: Cg. Rabbat et al., Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada, J AM S NEPH, 11(5), 2000, pp. 917-922
Authors:
Clase, CM
Norman, GL
Beecroft, ML
Churchill, DN
Citation: Cm. Clase et al., Albumin-corrected calcium and ionized calcium in stable haemodialysis patients, NEPH DIAL T, 15(11), 2000, pp. 1841-1846
Authors:
Margetts, PJ
McMullin, JP
Rabbat, CG
Churchill, DN
Citation: Pj. Margetts et al., Peritoneal membrane transport and hypoalbuminemia: Cause or effect?, PERIT DIA I, 20(1), 2000, pp. 14-18
Authors:
Clark, WF
Churchill, DN
Forwell, L
Citation: Wf. Clark et al., To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy (vol 162, pg 195, 2000), CAN MED A J, 162(7), 2000, pp. 973-973
Authors:
Clark, WF
Churchill, DN
Forwell, L
Macdonald, G
Foster, S
Citation: Wf. Clark et al., To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy, CAN MED A J, 162(2), 2000, pp. 195-198
Authors:
Lindberg, J
Churchill, DN
Fishbane, S
Citation: J. Lindberg et al., Research directions: New clinical frontiers, AM J KIDNEY, 36(6), 2000, pp. S52-S61
Authors:
Krepinsky, J
Ingram, AJ
Churchill, DN
Citation: J. Krepinsky et al., Metabolic investigation of recurrent nephrolithiasis: Compliance with recommendations, UROLOGY, 56(6), 2000, pp. 915-920
Authors:
Oliver, MJ
Callery, SM
Thorpe, KE
Schwab, SJ
Churchill, DN
Citation: Mj. Oliver et al., Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study, KIDNEY INT, 58(6), 2000, pp. 2543-2545
Authors:
Misra, M
Vonesh, E
Churchill, DN
Moore, HL
Van Stone, JC
Nolph, KD
Citation: M. Misra et al., Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout, KIDNEY INT, 57(2), 2000, pp. 691-696
Authors:
Churchill, DN
Citation: Dn. Churchill, Implications of the Canada-USA (CANUSA) multicentre trial, TEXTBOOK OF PERITONEAL DIALYSIS, 2ND EDITION, 2000, pp. 799-807
Authors:
Churchill, DN
Citation: Dn. Churchill, Continuous ambulatory peritoneal dialysis - Commentary, J AM S NEPH, 10(4), 1999, pp. 904
Authors:
Churchill, DN
Citation: Dn. Churchill, Clinical practice guidelines of the Canadian Society of Nephrology for Treatment of Patients with Chronic Renal Failure - Introduction, J AM S NEPH, 10, 1999, pp. S287-S288
Authors:
Churchill, DN
Blake, PG
Jindal, KK
Toffelmire, EB
Goldstein, MB
Citation: Dn. Churchill et al., Chapter 1: Clinical practice guidelines for initiation of dialysis, J AM S NEPH, 10, 1999, pp. S289-S291
Authors:
Churchill, DN
Citation: Dn. Churchill, Cardiac ischemia in the diabetic patient with end-stage renal disease, PERIT DIA I, 19(4), 1999, pp. 305-308
Risultati:
1-18
|